Prosecution Insights
Last updated: April 19, 2026

Nkarta, Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18024012 ENHANCED EXPANSION AND CYTOTOXICITY OF ENGINEERED NATURAL KILLER CELLS AND USES THEREOF VAN BUREN, LAUREN K 1638 Non-Final OA Feb 28, 2023
17758116 BCMA-DIRECTED CELLULAR IMMUNOTHERAPY COMPOSITIONS AND METHODS O'BRIEN, LEA S 1646 Non-Final OA Jun 28, 2022
17628105 METHODS AND COMPOSITIONS FOR ENHANCED EXPANSION AND CYTOTOXICITY OF NATURAL KILLER CELLS RIGA, MICHAEL ANGELO 1634 Non-Final OA Jan 18, 2022

Managing Nkarta, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month